How to Save Money on Ingrezza in 2026: Coupons, Discounts, and Patient Assistance

At a retail price of roughly $7,900–$8,700 per month, Ingrezza (valbenazine) is one of the higher-cost specialty medications on the market. But here's the good news: most patients pay a fraction of that — or nothing at all — thanks to a robust set of savings programs. This guide covers every option available in 2026.

How Much Does Ingrezza Cost Without Insurance?

The average wholesale price (AWP) for a 28-day supply of Ingrezza is approximately:

40 mg (30 capsules): ~$5,750–$7,921

80 mg (30 capsules): ~$6,225–$8,702

There is no generic valbenazine available. Because it is a specialty drug, it is not sold at standard retail pharmacies and GoodRx-style coupons do not apply in the traditional sense. However, the programs below can dramatically reduce what you actually pay.

Option 1: INBRACE Savings Card (Commercial Insurance Patients)

If you have commercial (non-government) insurance, the INBRACE Savings Card from Neurocrine Biosciences can reduce your out-of-pocket cost to as low as $0 per month.

Who qualifies: Patients with commercial (employer-sponsored or marketplace) insurance. Not valid for Medicare, Medicaid, TRICARE, or other government-funded plans.

How to enroll: Automatically enrolled when your doctor submits the INGREZZA Treatment Form. Or call 1-844-647-3992. The card is applied at the specialty pharmacy.

Typical cost: Most patients on commercial insurance pay $10 or less per month.

Option 2: Patient Assistance Program (Uninsured or Underinsured)

If you are uninsured, have no prescription coverage, or demonstrate a qualifying financial need, Neurocrine's Patient Assistance Program (PAP) provides Ingrezza at no cost.

Program name: Neurocrine Access Support Patient Assistance Program

How to apply: Call 1-844-647-3992 or visit inbracesupportprogram.com. Your doctor can also apply on your behalf.

Eligibility: Based on income, insurance status, and financial need. Program terms and conditions apply.

Option 3: INGREZZA 30-Day Free Trial (New Patients)

New patients can get a free 30-day supply of Ingrezza through the INGREZZA Start Program. This is especially useful while waiting for prior authorization approval, so you don't have to go without medication during the insurance review period.

How to enroll: Your prescriber submits the enrollment form (available at ingrezza.neurocrineaccesssupport.com). This is not contingent on any purchase.

Note: Cannot be submitted for third-party reimbursement. Valid for new Ingrezza patients only.

Option 4: Medicare and Medicaid Patients

Medicare patients cannot use the commercial savings card, but approximately 46% of Medicare Part D plans do cover Ingrezza. After the 2026 Medicare Part D out-of-pocket cap of $2,100, your plan covers 100% of remaining costs for the year. Low-income patients may qualify for Medicare Extra Help (Low Income Subsidy), which can significantly reduce costs.

For Medicaid patients, coverage and prior authorization requirements vary by state. Contact your state Medicaid program or ask your specialty pharmacy to run a benefits check.

Option 5: 90-Day Supply for Cost Savings

If approved by your insurance, getting a 90-day supply through your specialty pharmacy's mail-order service may reduce per-fill costs and reduce the frequency of copays. Ask your specialty pharmacy or insurance provider if a 90-day supply option is available for your plan.

Summary: Ingrezza Savings Options at a Glance

Commercial insurance: INBRACE Savings Card → $0–$10/month. Call 1-844-647-3992.

Uninsured/underinsured: Patient Assistance Program → Ingrezza at no cost if you qualify. Call 1-844-647-3992.

New patients: 30-Day Free Trial → ask your doctor to enroll you.

Medicare: $2,100 annual out-of-pocket cap (2026); Extra Help program for low-income patients.

Once you have your savings programs in place and just need help finding a pharmacy that can fill your Ingrezza, medfinder can locate a pharmacy near you that can fill your prescription — quickly and without the phone tag.

Also read: Why is Ingrezza so hard to find? for context on access challenges.